Study on NGM120 for Colorectal Cancer Patients with Cancer-Related Weight Loss
Sponsor: NGM Biopharmaceuticals, Inc
ClinicalTrials ID:NCT07033026
This clinical trial is testing a new treatment, NGM120, to see if it can help people with colorectal cancer who are experiencing cancer-related weight loss, known as cachexia. The study is designed to compare the effects of NGM120 with a placebo.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The purpose of this study is to evaluate the effectiveness, safety, and tolerability of a new treatment called NGM120 in people with colorectal cancer who are also experiencing significant weight loss due to their cancer, a condition known as cachexia. The study is conducted across multiple centers and involves participants being randomly assigned to receive either NGM120 or a placebo, without knowing which one they are receiving.
Description
This clinical trial is focused on understanding how well NGM120 works and how safe it is for people with colorectal cancer who are also dealing with cancer-related weight loss, called cachexia. The study is set up so that neither the participants nor the researchers know who is receiving the actual treatment and who is receiving a placebo, which is a substance with no active medication. This helps ensure the results are unbiased. Participants will be monitored for any changes in their condition and any side effects they might experience during the study.
Eligibility Criteria
Inclusion Criteria
- Have a confirmed diagnosis of colorectal cancer.
- Experience significant weight loss due to cancer, as defined by specific medical criteria.
- Agree to participate by signing an informed consent form.
Exclusion Criteria
- Have other treatable causes of reduced food intake.
- Are currently receiving nutrition through a feeding tube or intravenous methods.
- Have weight loss due to reasons other than cancer.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| NGM Clinical Study Site | 78041 | Laredo | Texas |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.